Your search for ‘Goodwin Procter LLP’ returned 4,533 results

As the 2023 proxy season draws to a close, Goodwin's PCAP has prepared a reminder about the Say-on-Frequency Form 8-K Reminder.

On May 19, 2022, Viatris Inc. and Biocon Biologics Ltd. announced that ABEVMY, a bevacizumab biosimilar, is now available in Canada. According to the press release, Viatris and Biocon Biologics...

The Department of Defense has updated its Section 1260H list of Chinese military companies, adding WuXi AppTec and 27 other entities.

On October 30, 2024, Shanghai Henlius Biotech and Organon announced that the FDA has accepted the Biologic License Application (BLA) for HLX14, a proposed biosimilar to PROLIA/XGEVA (denosumab).

We first reported on MAILISHU's approval on Big Molecule Watch's China blog.

The European Medicines Agency's (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

GSK plc has entered into an agreement to acquire a trispecific T cell-engager from Chimagen Biosciences, targeting multiple myeloma treatment with improved tolerability. The innovative therapeutic approach aims to bind T cells while simultaneously targeting two tumor-associated antigens, potentially enabling broader adoption in earlier treatment stages. This marks GSK's second acquisition from Chimagen, following their October 2024 deal for a dual CD19/CD20-targeted TCE.

The King's Speech announced the Pension Schemes Bill to boost defined contribution (DC) pension investments in long-term assets, facilitate pension pot consolidation, introduce a value-for-money framework, and consolidate the defined benefit (DB) market through superfunds.

On April 15, 2022, the Federal Trade Commission (FTC) announced that it obtained a permanent injunction against an Illinois-based, offshore, for-profit medical school for deceptive marketing practices.

The SEC's Division of Corporation Finance has issued a groundbreaking no-action letter to Tesla that significantly expands the scope of issuer voluntary retail voting programs beyond previous guidance. This development introduces new flexibilities including centralized multi-issuer hubs, standing instructions, and householding capabilities that could fundamentally reshape how retail shareholders participate in corporate governance.

On February 15, 2022, the SEC announced settlements with 12 broker-dealers and investment advisers for failing to satisfy their Form CRS obligations.

Numerous public companies have decided to hold virtual shareholder meetings this year. For 2022 virtual-only shareholder meetings

On November 7, 2024, the CFPB ann​ounced​​ that it had entered into​ a consent order with a major credit union​​ resolving ​allegations that the credit union improperly assessed overdraft fees against consumers​​.

On October 10, 2023, the Consumer Financial Protection Bureau (CFPB) announced that it filed a complaint​ against a residential mortgage loan originator and servicer alleging that the company violated...

In December 2024, the Consumer Financial Protection Bureau (CFPB) finalized a rule that closes a loophole exempting overdraft loans from lending laws, a major step in the CFPB's efforts to curb junk fees.

On March 30, 2022, the Consumer Financial Protection Bureau (CFPB) announced that it entered into a consent order with a student-loan servicer for...

On May 31, 2023, the Consumer Financial Protection Bureau (CFPB) announced that it had entered into a consent order with an Indiana-based non-bank installment lender.

On September 28, 2022, the Consumer Financial Protection Bureau (CFPB) an​nounced that it ordered an Alabama bank to pay over $190 million to resolve allegations...